Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ASX ANNOUNCEMENT 8 April 2022
This announcement contains inside information
88 Energy Limited
Project Icewine - Preliminary Mapping Complete, Resource Update Pending, Farm-In Discussions Advancing
Highlights
• Preliminary third-party mapping of the Shelf Margin Delta (SMD) play indicates extension of the SMD play fairway, where neighbour Pantheon Resources has had significant success in recent months, onto 88E’s Project Icewine leases.
• Mapping of Seabee Lower Basin Floor Fan (BFF) and Slope Fan System (SFS) approaching finalisation.
• Completion of independent resource update for Project Icewine scheduled for Q2 2022.
• Discussions and negotiations with potential Project Icewine farm-in parties ongoing.
• Development of forward work-program to assess the potential of the SMD, SFS and BFF play fairways on the Project Icewine acreage is progressing.
88 Energy Limited (ASX:88E, AIM:88E, OTC:EEENF) (88 Energy or the Company) is pleased to report that the ongoing assessment of the SMD, SFS and BFF play fairways onto its Project Icewine acreage (75% 88 Energy WI) is progressing as planned.
Preliminary independent third-party mapping using available well information from presentations publicly released by neighbouring acreage holder, Pantheon Resources (AIM:PANR) (Pantheon), plus internal 88E data, including Icewine-1 and Icewine-2 well logs and existing 2D seismic, indicates that all play fairways extend into the Project Icewine lease holding.
The source rocks (GRZ/HRZ) for the Brookian plays within the Project Icewine area are modelled to be within the oil mature window, with historical wells reporting abundant oil shows and interpreted oil saturations from electric log data.
Recent Pantheon wells – Alkaid-1, Talitha-A and Theta West-1 – have flowed 35 to 400 API oil from multiple Brookian reservoirs. Pantheon testing has confirmed reservoir deliverability of light, sweet oil (see Pantheon releases of 7 and 21 February 2022), which 88 Energy believes is positive for the prospectivity of the adjacent Project Icewine acreage.
Pantheon drilled the Talitha-A well, which is located just 2.8 miles north of the Project Icewine permit boundary, in Q1 2021. The well was suspended following a production test of the Kuparuk, with Pantheon announcing its intention to return to test additional targets, namely the BFF, the SFS and the SMD, during the 2022 drilling season. Earlier this year, Pantheon re-entered the Talitha-A well and individually flow-tested the BFF target and the SFS target, which resulted in the sustained recovery of light oil over a three-day period from each test. All targets are interpreted by the Company, and independently, to extend into the Project Icewine acreage.
www.88energy.com
ABN 80 072 964 179
Ground Floor, 516 Hay Street, Subiaco WA 6008 PO Box 352, Subiaco WA 6904 Australia Phone +61 8 9485 0990
Figure 1: Preliminary third-party mapping of SMD indicates extension of play fairway onto Project Icewine
The results of Pantheon’s Talitha-A well, combined with its earlier Alkaid-1 (2019) well, have been considered as part of a re-evaluation of 88 Energy’s Icewine-1 well data. Subsequent and independent comparisons of the zone that was tested and flowed light oil in Alkaid-1 at “80-100 BOPD light oil” (see Pantheon release of 25 March 2019) against the Icewine-1 well, have revealed the porosity and resistivity of a similar 110 ft net section in Icewine-1 well to be higher. Higher porosity is indicative of better reservoir quality and higher resistivity is an indicator that greater amounts of hydrocarbons are present. Given the favourable petrophysical comparison between Icewine-1 and Alkaid-1, the Company is optimistic that a production test in the Eastern Icewine acreage could yield a similar or better result than seen during the testing of Alkaid-1.
Following the successful testing at Talitha-A, Pantheon moved to test the BFF fan prospect in their Theta West well, reporting “light 35.5-38.5 degree API gravity oil at rates that averaged over 57 barrels of oil per day” (see Pantheon release of 24 March 2022). All reported Pantheon tests to date have been performed on vertical, stimulated wells.
Following the recent results from the Talitha-A and Theta West-1 wells drilled by Pantheon, 88 Energy has a positive view of the potential of the SMD, SFS and BFF play fairways that extend onto the Icewine acreage. In particular, the Company notes the relative consistency of results over a large area to the north, suggestive of reasonably homogeneous reservoirs that potentially extend into 88 Energy’s acreage. The Company also notes Pantheon’s planned development wells are expected to produce at rates of over 1,000 BOPD per well via long horizontal wells with multi-stage hydraulic fracturing technology (see Pantheon release of 24 January 2022).
Page 2 of 5
Figure 2: Shelf Margin Delta Sequence Correlation Panel
88 Energy is in the process of finalising mapping of the SFS and BFF play fairways onto the Icewine acreage and expects this work to be completed in April 2022. Once complete, the combined mapping of the three prospects (SMD, SFS and BFF) is set to form the basis of an updated resource estimate at Project Icewine, scheduled for completion in Q2 2022.
88 Energy advises that it is in ongoing discussions in relation to a potential farm-out of the Project Icewine acreage. Due diligence activities and negotiations are advancing with regard to the potential farm-in by a third party and the related work program terms and structure. Execution and completion of the potential transaction is not guaranteed and remains subject to all final documentation being agreed and due diligence completed. There is no guarantee that negotiations will lead to a binding agreement or a completed transaction.
Page 3 of 5
This announcement has been authorised by the Board.
Media and Investor Relations:
88 Energy Ltd
Ashley Gilbert, Managing Director
Tel: +61 8 9485 0990 Email:investor-relations@88energy.com
Finlay Thomson, Investor Relations
Fivemark Partners, Investor and Media Relations
Andrew Edge / Michael Vaughan
EurozHartleys Ltd
Dale Bryan
Cenkos Securities
Neil McDonald / Derrick Lee
Tel: +44 7976 248471
Tel: +61 410 276 744 Tel: +61 422 602 720
Tel: + 61 8 9268 2829 Tel: + 44 131 220 6939
Pursuant to the requirements of the ASX Listing Rules Chapter 5 and the AIM Rules for Companies, the technical information and resource reporting contained in this announcement was prepared by, or under the supervision of, Dr Stephen Staley, who is a Non-Executive Director of the Company. Dr Staley has more than 35 years' experience in the petroleum industry, is a Fellow of the Geological Society of London, and a qualified Geologist/Geophysicist who has sufficient experience that is relevant to the style and nature of the oil prospects under consideration and to the activities discussed in this document. Dr Staley has reviewed the information and supporting documentation referred to in this announcement and considers the resource and reserve estimates to be fairly represented and consents to its release in the form and context in which it appears. His academic qualifications and industry memberships appear on the Company's website and both comply with the criteria for "Competence" under clause 3.1 of the Valmin Code 2015. Terminology and standards adopted by the Society of Petroleum Engineers "Petroleum Resources Management System" have been applied in producing this document.
Page 4 of 5
About Project Icewine
Project Icewine is located on the central North Slope of Alaska and encompasses approximately 195,000 acres. It is situated on-trend to recent discoveries in multiple, newly successful play types in topset and bottom-set sands of the Schrader Bluff and Seabee formations. 88 Energy has a 75% working interest in the Project.
88 Energy has acquired 2D and 3D seismic and drilled three exploration wells in the acreage, including the Charlie-1 discovery well in Q1 CY2020.
Project Icewine and Near Lease Discoveries
Note:
1. Talitha-A well was drilled and tested by Pantheon Resources LLC in Q1 2021
2. Please refer to the ASX release dated 10 November 2020 for full details with respect to the Prospective Resource
estimate, associated risking
3. Cautionary Statement: The estimated quantities of petroleum that may be potentially recovered by the application of a
future development project relate to undiscovered accumulations. These estimates have both an associated risk of discovery and a risk of development. Further exploration, appraisal and evaluation are required to determine the existence of a significant quantity of potentially movable hydrocarbons. Page 5 of 5
Yep time to exit
LIMITED
88E
LAST PRICE
$0.016
TODAY'S CHANGE
-$0.017 (-50.00%)
VOLUME
650,263,977
BID/OFFER RANGE
$0.016 - $0.017
MARKET CAP
$524.21M
Industry Group: Energy
Listed on 20 January 2000
Australia Market
Australias board
ENERGY LIMITED
88E
LAST PRICE
0.051
TODAY'S CHANGE
+0.002 (5.10%)
VOLUME
52,022,881
BID/OFFER RANGE
$0.051 - $0.052
MARKET CAP
725.74M
Energy
Listed on 20 January 2000
Prices delayed by at least 20 minutes | Currently trading
88E Overview
1d1m3m6mYTD1yr3yr5yr10yr
How come no news on the 8k today
Shaken the tree pretty hard
Hang on cause here we go please tighten your seat belts
Pre trades ?
Stock Screener
Market ActivityStockRGBPOverview
RGBP
Regen Biopharma, Inc.
Common Stock
0.06965
0.00685
10.91%
0.0696 / 0.0697 (1 x 1)
Real-Time Best Bid & Ask: 05:00pm 08/27/2021
Delayed (15 Min) Trade Data: 12:00am 08/27/2021
Pink Current Information
Transfer Agent Verified
Overview
Nice close
F@&ken MMs
Hang on boys and girls
Just putting out information for people to make an informed decision as to what they want to do.
From E Trade
New regulations will affect your ability to buy and sell “Pink No Information,” “Grey Market,” and “Expert Market” Over-the-Counter (OTC) securities, including at E*TRADE.
On September 28, 2021, new amendments to Rule 15c2-11 under the Securities Exchange Act of 1934 take effect that will impact the market for certain OTC securities classified as Pink No Information, Grey Market, and Expert Market OTC securities (collectively, “Impacted OTC Securities”). These rule changes prohibit broker-dealers, like E*TRADE, from publishing bid/ask quotations of companies that fail to publicly report and keep current financial and other company information. The amendments also restrict the ability of retail investors to open new positions in Impacted OTC Securities.
What these rule changes mean for you
After Friday, August 27, 2021, E*TRADE customers will no longer be able to buy Impacted OTC Securities through E*TRADE. E*TRADE will restrict new buy orders in Impacted OTC Securities prior to the regulatory enforcement date, as it may become more difficult to liquidate such securities after the compliance deadline. While E*TRADE will accept closing orders to liquidate positions in these securities after the amendment goes into effect on September 28, 2021, it may be more difficult to sell these securities, as quoting and market liquidity may be very limited. The following restrictions will apply to any closing order for Impacted OTC Securities:
You must not be an Affiliate, Insider, or Control Person of the company
Only limit orders will be accepted
Quotes for the security will not be available
Other restrictions related to the purchase and sale of these securities may also apply.
Please visit OTC Markets Group’s website to see if any OTC securities you hold are currently categorized as a Pink No Information, Grey Market or Expert Market security.¹
Sounds like a buyout is coming
https://apple.news/AC_uKQVo8RguZ3TtaTEsPTQ
Check this out
I am still holding and yes it’s pretty quit around here
Thanks
Thanks Still work but trade as a hobby paid cash in 2019 for a 2019 street glide with stage 4 upgrades with penny stock money.
Quit drinking 4 yrs ago now I put my extra money in crypto and penny stocks
Typo on first message supposed to be 114,850,914
Just bought another 36,144,578 on the dip.
Now holding 150,995,492. And holding
Holding 141,850,914. Not selling this will pass just got to HOLD!
Oncology Pharma, Inc. Is Pursuing the Development of Its Small Molecule Drug for the Treatment of Colon Cancer
Source: InvestorsHub NewsWire
San Francisco, CA -- May 18, 2021 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC: ONPH) Oncology Pharma, Inc. (the “Company”) is pursuing, through its licensing arrangements, the development of a small molecule drug (“SMD”) for the treatment of colon cancer. SMD is defined as any organic compound that enters cells easily because it has low molecular weight (< 900 daltons). Once inside the cells, it can affect other molecules, such as proteins, and may cause cancer cells to die. This is different from drugs that have a large molecular weight, which keep them from getting inside cells easily. Their small size makes them easily ingestible in the gastrointestinal tract where active substances are immediately absorbed into the bloodstream and can travel anywhere in the body. The small size of these molecules allows them to easily penetrate cell membranes as they travel throughout the body.
SMD’s have a preference, if successfully developed, over “large molecule”, or biologics, in that SMD’s can be generally taken orally, easier to use, more accessible, and usually do not require doctor visits at time of administration. Many targeted therapies have in the past been small molecules. In the last several years large pharma companies have been developing biologics and have chosen to acquire smaller companies that have been developing small-molecule drugs. They generally have a lower cost to the patient. The successful development of SMDs has great interest by larger pharmaceutical companies due to the widely available attributes that have a demand on a global basis.
Oncology Pharma, Inc. Addresses Pancreatic Cancer, The Need For An Effective Therapy And The Potential of mRNA
Source: InvestorsHub NewsWire
San Francisco, CA -- April 14, 2021 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC: ONPH) On April 7, 2021 Oncology Pharma, Inc. ( the "Company") reported that it had been granted an exclusive worldwide license by Regen BioPharma, Inc. to develop and commercialize pancreatic cancer treatments utilizing Regen's proprietary intellectual property pertaining to mRNA.
A Spokesperson for the Company, today expanded on the reasons for obtaining this license stating:
"Pancreatic Cancer is one of the most lethal forms of cancer ranking as the fourth leading cause of cancer deaths in the United States. The median survival duration from diagnosis until death for untreated advanced pancreatic cancer is approximately 3 1/2 months; increasing to about eight months with treatment.
mRNA vaccines have become a promising platform for cancer immunotherapy. The intellectual property which we licensed from Regen encompasses an exciting method of utilizing mRNA to cause changes in the cancer cells which would stimulate the patient's own immune response to battle this deadly disease.
According to the National Cancer Institute more than 1.7 million new cases of pancreatic cancer emerge in the United States per year resulting in 609,604 deaths. The cost of treating pancreatic cancer in the United States is $174 billion per year and growing. These are staggering numbers.
We believe that developing a solid therapy to treat this disease is our mission. We want to help save lives and bring hope where currently little hope exists. We believe our mRNA based pancreatic cancer therapies will prove dynamic and powerful."
The Spokesperson further noted "We are more than a biotechnology company. We believe our shareholders expect us to not only develop therapies that improve lives but to develop therapies that save lives. Knowing what we know about pancreatic cancer, this is a great cornerstone on which to focus our Company's research activities."
Look how desperate the shorts are
Waiting patiently
Waiting patiently
Pre trades already wtf?
Yet the fun begin I am in.
Have seen you on a few stocks, I don’t post a lot like to observe in the shadows
Might take a starter
Is this the next EEENf?
They didn’t
Nothing wrong with taking profits. Will re enter at discount price tomorrow and ride it up again. I don’t play games just trying to make money like everyone else.
No .0888